Form 4: Oric Pharmaceuticals CFO Sells Shares

Sentiment:

Insider Transaction (Form 4)


Dominic Piscitelli, Chief Financial Officer of Oric Pharmaceuticals, Inc., sold 600 shares of common stock on September 24, 2026.

Summary

  • Option exercise/conversion: acquired 600 Common Stock at $4.36 ($2,616) on September 24, 2026; holds 70,428 after (Direct).
  • Open-market sale: disposed of 100 Common Stock at $13.50 ($1,350) on September 24, 2026; holds 70,328 after (Direct).
  • Open-market sale: disposed of 500 Common Stock at $13.51 ($6,752) on September 24, 2026; holds 69,828 after (Direct).
  • Option exercise/conversion: disposed of 600 Stock Option (right to buy) on September 24, 2026; holds 91,900 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $8,102 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Dominic Piscitelli — Officer (Chief Financial Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-09-24Option exercise/conversionCommon Stock600$4$2.6K70,428
2026-09-24Open-market saleCommon Stock100$14$1.4K70,328
2026-09-24Open-market saleCommon Stock500$14$6.8K69,828
2026-09-24Option exercise/conversionStock Option (right to buy)600——91,900

Key Dates

DateDescription
2026-09-24Option exercise/conversion (600 shares)
2026-09-24Open-market sale (100 shares)
2026-09-24Open-market sale (500 shares)
2026-09-24Option exercise/conversion (600 shares)

Keywords

insider transaction, Form 4, ORIC, Oric Pharmaceuticals, Inc., bearish, Dominic Piscitelli

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.